#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Several bacterial taxa , such as enteropathogenic Escherichia coli , Helicobacter pylori , Staphylococcus aureus , and Shigella flexneri , survive by preventing apoptosis .
2-1	14-21	Several	animal[3]	new[3]	_	_
2-2	22-31	bacterial	substance|animal[3]	new|new[3]	_	_
2-3	32-36	taxa	animal[3]	new[3]	_	_
2-4	37-38	,	animal[3]	new[3]	_	_
2-5	39-43	such	animal[3]	new[3]	_	_
2-6	44-46	as	animal[3]	new[3]	_	_
2-7	47-63	enteropathogenic	animal[3]	new[3]	_	_
2-8	64-75	Escherichia	animal[3]	new[3]	_	_
2-9	76-80	coli	animal[3]	new[3]	_	_
2-10	81-82	,	animal[3]	new[3]	_	_
2-11	83-95	Helicobacter	animal[3]|person|place[5]	new[3]|new|new[5]	_	_
2-12	96-102	pylori	animal[3]|place[5]	new[3]|new[5]	_	_
2-13	103-104	,	animal[3]	new[3]	_	_
2-14	105-119	Staphylococcus	animal[3]|abstract	new[3]|new	_	_
2-15	120-126	aureus	animal[3]	new[3]	_	_
2-16	127-128	,	animal[3]	new[3]	_	_
2-17	129-132	and	animal[3]	new[3]	_	_
2-18	133-141	Shigella	animal[3]|person	new[3]|new	_	_
2-19	142-150	flexneri	animal[3]	new[3]	_	_
2-20	151-152	,	_	_	_	_
2-21	153-160	survive	_	_	_	_
2-22	161-163	by	_	_	_	_
2-23	164-174	preventing	_	_	_	_
2-24	175-184	apoptosis	abstract	new	coref	11-7
2-25	185-186	.	_	_	_	_

#Text=Disruption of the mitochondrial fusion/fission balance leads to increased mitochondrial fragmentation .
3-1	187-197	Disruption	abstract[9]	new[9]	_	_
3-2	198-200	of	abstract[9]	new[9]	_	_
3-3	201-204	the	abstract[9]|abstract[12]	new[9]|new[12]	coref	7-10[42_12]
3-4	205-218	mitochondrial	abstract[9]|object|abstract[12]	new[9]|new|new[12]	coref	7-2
3-5	219-233	fusion/fission	abstract[9]|object|abstract[12]	new[9]|new|new[12]	coref	7-12
3-6	234-241	balance	abstract[9]|abstract[12]	new[9]|new[12]	_	_
3-7	242-247	leads	_	_	_	_
3-8	248-250	to	_	_	_	_
3-9	251-260	increased	abstract[13]	new[13]	coref	4-14[19_13]
3-10	261-274	mitochondrial	abstract[13]	new[13]	_	_
3-11	275-288	fragmentation	abstract[13]	new[13]	_	_
3-12	289-290	.	_	_	_	_

#Text=In this study , we showed that infection with attenuated Ra Mtb induced greater mitochondrial fragmentation than infection with Rv Mtb .
4-1	291-293	In	_	_	_	_
4-2	294-298	this	abstract[14]	new[14]	coref	15-1[101_14]
4-3	299-304	study	abstract[14]	new[14]	_	_
4-4	305-306	,	_	_	_	_
4-5	307-309	we	person	acc	ana	13-3
4-6	310-316	showed	_	_	_	_
4-7	317-321	that	_	_	_	_
4-8	322-331	infection	abstract[16]	new[16]	coref	4-18[20_16]
4-9	332-336	with	abstract[16]	new[16]	_	_
4-10	337-347	attenuated	abstract[16]|abstract[18]	new[16]|new[18]	coref	4-20[22_18]
4-11	348-350	Ra	abstract[16]|person|abstract[18]	new[16]|new|new[18]	coref	12-11
4-12	351-354	Mtb	abstract[16]|abstract[18]	new[16]|new[18]	_	_
4-13	355-362	induced	_	_	_	_
4-14	363-370	greater	abstract[19]	giv[19]	coref	7-1[39_19]
4-15	371-384	mitochondrial	abstract[19]	giv[19]	_	_
4-16	385-398	fragmentation	abstract[19]	giv[19]	_	_
4-17	399-403	than	abstract[19]	giv[19]	_	_
4-18	404-413	infection	abstract[19]|abstract[20]	giv[19]|giv[20]	coref	8-19[51_20]
4-19	414-418	with	abstract[19]|abstract[20]	giv[19]|giv[20]	_	_
4-20	419-421	Rv	abstract[19]|abstract[20]|abstract|abstract[22]	giv[19]|giv[20]|new|giv[22]	coref|coref	5-23|8-19[0_22]
4-21	422-425	Mtb	abstract[19]|abstract[20]|abstract[22]	giv[19]|giv[20]|giv[22]	_	_
4-22	426-427	.	_	_	_	_

#Text=However , the levels of MMP , OCR , and ATP were significantly lower in Ra-infected macrophages than in those infected with Rv .
5-1	428-435	However	_	_	_	_
5-2	436-437	,	_	_	_	_
5-3	438-441	the	abstract[23]	new[23]	_	_
5-4	442-448	levels	abstract[23]	new[23]	_	_
5-5	449-451	of	abstract[23]	new[23]	_	_
5-6	452-455	MMP	abstract[23]|substance|substance[25]	new[23]|new|new[25]	coref|coref	6-15[34_0]|6-15[35_25]
5-7	456-457	,	abstract[23]|substance[25]	new[23]|new[25]	_	_
5-8	458-461	OCR	abstract[23]|substance[25]|substance	new[23]|new[25]|new	coref	8-8
5-9	462-463	,	abstract[23]|substance[25]	new[23]|new[25]	_	_
5-10	464-467	and	abstract[23]|substance[25]	new[23]|new[25]	_	_
5-11	468-471	ATP	abstract[23]|substance[25]|substance	new[23]|new[25]|new	coref	6-18
5-12	472-476	were	_	_	_	_
5-13	477-490	significantly	_	_	_	_
5-14	491-496	lower	_	_	_	_
5-15	497-499	in	_	_	_	_
5-16	500-511	Ra-infected	animal[28]	new[28]	coref	7-15[0_28]
5-17	512-523	macrophages	animal[28]	new[28]	_	_
5-18	524-528	than	_	_	_	_
5-19	529-531	in	_	_	_	_
5-20	532-537	those	_	_	_	_
5-21	538-546	infected	_	_	_	_
5-22	547-551	with	_	_	_	_
5-23	552-554	Rv	substance	giv	coref	12-9
5-24	555-556	.	_	_	_	_

#Text=Mitochondrial dysfunction is reportedly increased in Ra- compared to Rv-infected THP-1 cells , decreasing the MMP and ATP synthesis .
6-1	557-570	Mitochondrial	abstract[30]	new[30]	_	_
6-2	571-582	dysfunction	abstract[30]	new[30]	_	_
6-3	583-585	is	_	_	_	_
6-4	586-596	reportedly	_	_	_	_
6-5	597-606	increased	_	_	_	_
6-6	607-609	in	_	_	_	_
6-7	610-613	Ra-	person	new	_	_
6-8	614-622	compared	_	_	_	_
6-9	623-625	to	_	_	_	_
6-10	626-637	Rv-infected	object[33]	new[33]	_	_
6-11	638-643	THP-1	event|object[33]	new|new[33]	_	_
6-12	644-649	cells	object[33]	new[33]	_	_
6-13	650-651	,	_	_	_	_
6-14	652-662	decreasing	_	_	_	_
6-15	663-666	the	substance[34]|substance[35]	giv[34]|giv[35]	coref|coref	8-6[0_34]|8-6[46_35]
6-16	667-670	MMP	substance[34]|substance[35]	giv[34]|giv[35]	_	_
6-17	671-674	and	substance[35]	giv[35]	_	_
6-18	675-678	ATP	substance[35]|substance	giv[35]|giv	coref	8-11
6-19	679-688	synthesis	substance[35]|abstract	giv[35]|new	_	_
6-20	689-690	.	_	_	_	_

#Text=Ra-induced mitochondrial fragmentation may be due to disruption of the mitochondrial fusion/fission balance in macrophages .
7-1	691-701	Ra-induced	abstract[39]	giv[39]	coref	8-16[49_39]
7-2	702-715	mitochondrial	abstract|abstract[39]	giv|giv[39]	coref	12-4
7-3	716-729	fragmentation	abstract[39]	giv[39]	_	_
7-4	730-733	may	_	_	_	_
7-5	734-736	be	_	_	_	_
7-6	737-740	due	_	_	_	_
7-7	741-743	to	_	_	_	_
7-8	744-754	disruption	abstract[40]	new[40]	_	_
7-9	755-757	of	abstract[40]	new[40]	_	_
7-10	758-761	the	abstract[40]|abstract[42]	new[40]|giv[42]	_	_
7-11	762-775	mitochondrial	abstract[40]|abstract[42]	new[40]|giv[42]	_	_
7-12	776-790	fusion/fission	abstract[40]|object|abstract[42]	new[40]|giv|giv[42]	coref	12-19
7-13	791-798	balance	abstract[40]|abstract[42]	new[40]|giv[42]	_	_
7-14	799-801	in	abstract[40]|abstract[42]	new[40]|giv[42]	_	_
7-15	802-813	macrophages	abstract[40]|abstract[42]|animal	new[40]|giv[42]|giv	coref	9-11[55_0]
7-16	814-815	.	_	_	_	_

#Text=Therefore , lower levels of MMP , OCR , and ATP may be associated with mitochondrial fragmentation during Mtb infection .
8-1	816-825	Therefore	_	_	_	_
8-2	826-827	,	_	_	_	_
8-3	828-833	lower	abstract[44]	new[44]	_	_
8-4	834-840	levels	abstract[44]	new[44]	_	_
8-5	841-843	of	abstract[44]	new[44]	_	_
8-6	844-847	MMP	abstract[44]|substance|substance[46]	new[44]|giv|giv[46]	coref	27-7[178_0]
8-7	848-849	,	abstract[44]|substance[46]	new[44]|giv[46]	_	_
8-8	850-853	OCR	abstract[44]|substance[46]|substance	new[44]|giv[46]|giv	_	_
8-9	854-855	,	abstract[44]|substance[46]	new[44]|giv[46]	_	_
8-10	856-859	and	abstract[44]|substance[46]	new[44]|giv[46]	_	_
8-11	860-863	ATP	abstract[44]|substance[46]|substance	new[44]|giv[46]|giv	_	_
8-12	864-867	may	_	_	_	_
8-13	868-870	be	_	_	_	_
8-14	871-881	associated	_	_	_	_
8-15	882-886	with	_	_	_	_
8-16	887-900	mitochondrial	abstract[49]	giv[49]	coref	12-4[78_49]
8-17	901-914	fragmentation	abstract[49]	giv[49]	_	_
8-18	915-921	during	abstract[49]	giv[49]	_	_
8-19	922-925	Mtb	abstract[49]|abstract|abstract[51]	giv[49]|giv|giv[51]	coref|coref	12-7[79_51]|13-18
8-20	926-935	infection	abstract[49]|abstract[51]	giv[49]|giv[51]	_	_
8-21	936-937	.	_	_	_	_

#Text=Production of MFN2 was significantly reduced in Ra- compared with Rv-infected macrophages .
9-1	938-948	Production	abstract[52]	new[52]	coref	12-19[85_52]
9-2	949-951	of	abstract[52]	new[52]	_	_
9-3	952-956	MFN2	abstract[52]|object	new[52]|new	coref	13-15
9-4	957-960	was	_	_	_	_
9-5	961-974	significantly	_	_	_	_
9-6	975-982	reduced	_	_	_	_
9-7	983-985	in	_	_	_	_
9-8	986-989	Ra-	abstract	new	_	_
9-9	990-998	compared	_	_	_	_
9-10	999-1003	with	_	_	_	_
9-11	1004-1015	Rv-infected	animal[55]	giv[55]	coref	10-16[61_55]
9-12	1016-1027	macrophages	animal[55]	giv[55]	_	_
9-13	1028-1029	.	_	_	_	_

#Text=In contrast , the levels of the fission proteins DRP1 and MFF were increased in Ra-infected macrophages compared to the control .
10-1	1030-1032	In	_	_	_	_
10-2	1033-1041	contrast	_	_	_	_
10-3	1042-1043	,	_	_	_	_
10-4	1044-1047	the	abstract[56]	new[56]	_	_
10-5	1048-1054	levels	abstract[56]	new[56]	_	_
10-6	1055-1057	of	abstract[56]	new[56]	_	_
10-7	1058-1061	the	abstract[56]|substance[58]	new[56]|new[58]	_	_
10-8	1062-1069	fission	abstract[56]|abstract|substance[58]	new[56]|new|new[58]	_	_
10-9	1070-1078	proteins	abstract[56]|substance[58]	new[56]|new[58]	_	_
10-10	1079-1083	DRP1	abstract[56]|abstract	new[56]|new	_	_
10-11	1084-1087	and	abstract[56]	new[56]	_	_
10-12	1088-1091	MFF	abstract[56]|object	new[56]|new	_	_
10-13	1092-1096	were	_	_	_	_
10-14	1097-1106	increased	_	_	_	_
10-15	1107-1109	in	_	_	_	_
10-16	1110-1121	Ra-infected	animal[61]	giv[61]	coref	15-14[107_61]
10-17	1122-1133	macrophages	animal[61]	giv[61]	_	_
10-18	1134-1142	compared	_	_	_	_
10-19	1143-1145	to	_	_	_	_
10-20	1146-1149	the	abstract[62]	new[62]	_	_
10-21	1150-1157	control	abstract[62]	new[62]	_	_
10-22	1158-1159	.	_	_	_	_

#Text=DRP1 induces cytochrome c release during apoptosis and MFN1/2 delays Bax activation , cytochrome c release , and apoptosis .
11-1	1160-1164	DRP1	person	new	_	_
11-2	1165-1172	induces	_	_	_	_
11-3	1173-1183	cytochrome	abstract[64]	new[64]	coref	11-14[0_64]
11-4	1184-1185	c	abstract[64]|abstract	new[64]|new	coref	11-15
11-5	1186-1193	release	event[66]	new[66]	_	_
11-6	1194-1200	during	event[66]	new[66]	_	_
11-7	1201-1210	apoptosis	event[66]|event	new[66]|giv	coref	11-19
11-8	1211-1214	and	event[66]	new[66]	_	_
11-9	1215-1221	MFN1/2	event[66]|event|abstract[69]	new[66]|new|new[69]	_	_
11-10	1222-1228	delays	event[66]|abstract[69]	new[66]|new[69]	_	_
11-11	1229-1232	Bax	event[66]|abstract[69]|person|event[71]	new[66]|new[69]|new|new[71]	_	_
11-12	1233-1243	activation	event[66]|abstract[69]|event[71]	new[66]|new[69]|new[71]	_	_
11-13	1244-1245	,	event[66]|abstract[69]	new[66]|new[69]	_	_
11-14	1246-1256	cytochrome	event[66]|abstract[69]|abstract	new[66]|new[69]|giv	_	_
11-15	1257-1258	c	event[66]|abstract[69]|abstract|event[74]	new[66]|new[69]|giv|new[74]	_	_
11-16	1259-1266	release	event[66]|abstract[69]|event[74]	new[66]|new[69]|new[74]	_	_
11-17	1267-1268	,	event[66]	new[66]	_	_
11-18	1269-1272	and	event[66]	new[66]	_	_
11-19	1273-1282	apoptosis	event[66]|event	new[66]|giv	coref	22-10[146_0]
11-20	1283-1284	.	_	_	_	_

#Text=The difference in mitochondrial fragmentation between infection with Rv and Ra is likely dependent on the levels of fusion/fission protein production .
12-1	1285-1288	The	abstract[76]	new[76]	_	_
12-2	1289-1299	difference	abstract[76]	new[76]	_	_
12-3	1300-1302	in	abstract[76]	new[76]	_	_
12-4	1303-1316	mitochondrial	abstract[76]|abstract|abstract[78]	new[76]|giv|giv[78]	coref|coref	13-8|13-7[89_78]
12-5	1317-1330	fragmentation	abstract[76]|abstract[78]	new[76]|giv[78]	_	_
12-6	1331-1338	between	abstract[76]|abstract[78]	new[76]|giv[78]	_	_
12-7	1339-1348	infection	abstract[76]|abstract[78]|abstract[79]	new[76]|giv[78]|giv[79]	coref	13-18[93_79]
12-8	1349-1353	with	abstract[76]|abstract[78]|abstract[79]	new[76]|giv[78]|giv[79]	_	_
12-9	1354-1356	Rv	abstract[76]|abstract[78]|abstract[79]|abstract	new[76]|giv[78]|giv[79]|giv	coref	19-21[129_0]
12-10	1357-1360	and	abstract[76]|abstract[78]|abstract[79]	new[76]|giv[78]|giv[79]	_	_
12-11	1361-1363	Ra	abstract[76]|abstract[78]|abstract[79]|person	new[76]|giv[78]|giv[79]|giv	coref	20-3
12-12	1364-1366	is	_	_	_	_
12-13	1367-1373	likely	_	_	_	_
12-14	1374-1383	dependent	_	_	_	_
12-15	1384-1386	on	_	_	_	_
12-16	1387-1390	the	abstract[82]	new[82]	coref	28-9[186_82]
12-17	1391-1397	levels	abstract[82]	new[82]	_	_
12-18	1398-1400	of	abstract[82]	new[82]	_	_
12-19	1401-1415	fusion/fission	abstract[82]|abstract|abstract[85]	new[82]|giv|giv[85]	coref	13-14[91_85]
12-20	1416-1423	protein	abstract[82]|substance|abstract[85]	new[82]|new|giv[85]	_	_
12-21	1424-1434	production	abstract[82]|abstract[85]	new[82]|giv[85]	_	_
12-22	1435-1436	.	_	_	_	_

#Text=Therefore , our data suggest that increased mitochondrial fragmentation may be caused by reduced MFN2 production during Mtb infection .
13-1	1437-1446	Therefore	_	_	_	_
13-2	1447-1448	,	_	_	_	_
13-3	1449-1452	our	person|abstract[87]	giv|new[87]	ana|coref	25-1|25-1[163_87]
13-4	1453-1457	data	abstract[87]	new[87]	_	_
13-5	1458-1465	suggest	_	_	_	_
13-6	1466-1470	that	_	_	_	_
13-7	1471-1480	increased	abstract[89]	giv[89]	coref	29-11[194_89]
13-8	1481-1494	mitochondrial	abstract|abstract[89]	giv|giv[89]	coref	26-9
13-9	1495-1508	fragmentation	abstract[89]	giv[89]	_	_
13-10	1509-1512	may	_	_	_	_
13-11	1513-1515	be	_	_	_	_
13-12	1516-1522	caused	_	_	_	_
13-13	1523-1525	by	_	_	_	_
13-14	1526-1533	reduced	abstract[91]	giv[91]	coref	14-8[98_91]
13-15	1534-1538	MFN2	object|abstract[91]	giv|giv[91]	coref	14-8
13-16	1539-1549	production	abstract[91]	giv[91]	_	_
13-17	1550-1556	during	abstract[91]	giv[91]	_	_
13-18	1557-1560	Mtb	abstract[91]|object|abstract[93]	giv[91]|giv|giv[93]	coref|coref	15-9|19-9[125_93]
13-19	1561-1570	infection	abstract[91]|abstract[93]	giv[91]|giv[93]	_	_
13-20	1571-1572	.	_	_	_	_

#Text=Parkin ( an E3 ligase ) reduces MFN2 production by ubiquitination in damaged mitochondria .
14-1	1573-1579	Parkin	person	new	coref	15-6
14-2	1580-1581	(	_	_	_	_
14-3	1582-1584	an	abstract[96]	new[96]	_	_
14-4	1585-1587	E3	abstract|abstract[96]	new|new[96]	_	_
14-5	1588-1594	ligase	abstract[96]	new[96]	_	_
14-6	1595-1596	)	_	_	_	_
14-7	1597-1604	reduces	_	_	_	_
14-8	1605-1609	MFN2	object|abstract[98]	giv|giv[98]	coref|coref	16-8|17-5[115_98]
14-9	1610-1620	production	abstract[98]	giv[98]	_	_
14-10	1621-1623	by	abstract[98]	giv[98]	_	_
14-11	1624-1638	ubiquitination	abstract[98]|substance[99]	giv[98]|new[99]	coref	17-12[0_99]
14-12	1639-1641	in	abstract[98]|substance[99]	giv[98]|new[99]	_	_
14-13	1642-1649	damaged	abstract[98]|substance[99]|place[100]	giv[98]|new[99]|new[100]	coref	30-8[0_100]
14-14	1650-1662	mitochondria	abstract[98]|substance[99]|place[100]	giv[98]|new[99]|new[100]	_	_
14-15	1663-1664	.	_	_	_	_

#Text=A recent study showed that Parkin induction limited Mtb survival through autophagy of Mtb-infected macrophages .
15-1	1665-1666	A	abstract[101]	giv[101]	coref	17-2[113_101]
15-2	1667-1673	recent	abstract[101]	giv[101]	_	_
15-3	1674-1679	study	abstract[101]	giv[101]	_	_
15-4	1680-1686	showed	_	_	_	_
15-5	1687-1691	that	_	_	_	_
15-6	1692-1698	Parkin	person|abstract[103]	giv|new[103]	coref	16-6
15-7	1699-1708	induction	abstract[103]	new[103]	_	_
15-8	1709-1716	limited	_	_	_	_
15-9	1717-1720	Mtb	abstract|event[105]	giv|new[105]	coref|coref	16-12|28-15[187_105]
15-10	1721-1729	survival	event[105]	new[105]	_	_
15-11	1730-1737	through	_	_	_	_
15-12	1738-1747	autophagy	abstract[106]	new[106]	_	_
15-13	1748-1750	of	abstract[106]	new[106]	_	_
15-14	1751-1763	Mtb-infected	abstract[106]|animal[107]	new[106]|giv[107]	coref	21-11[142_107]
15-15	1764-1775	macrophages	abstract[106]|animal[107]	new[106]|giv[107]	_	_
15-16	1776-1777	.	_	_	_	_

#Text=However , the relationship between Parkin and MFN2 is unclear during Mtb infections .
16-1	1778-1785	However	_	_	_	_
16-2	1786-1787	,	_	_	_	_
16-3	1788-1791	the	abstract[108]	new[108]	_	_
16-4	1792-1804	relationship	abstract[108]	new[108]	_	_
16-5	1805-1812	between	abstract[108]	new[108]	_	_
16-6	1813-1819	Parkin	abstract[108]|person	new[108]|giv	coref	17-6
16-7	1820-1823	and	abstract[108]	new[108]	_	_
16-8	1824-1828	MFN2	abstract[108]|abstract	new[108]|giv	coref	17-9
16-9	1829-1831	is	_	_	_	_
16-10	1832-1839	unclear	_	_	_	_
16-11	1840-1846	during	_	_	_	_
16-12	1847-1850	Mtb	object|abstract[112]	giv|new[112]	coref	26-16
16-13	1851-1861	infections	abstract[112]	new[112]	_	_
16-14	1862-1863	.	_	_	_	_

#Text=In this study , Mtb-mediated Parkin production decreased MFN2 production via ubiquitination .
17-1	1864-1866	In	_	_	_	_
17-2	1867-1871	this	abstract[113]	giv[113]	_	_
17-3	1872-1877	study	abstract[113]	giv[113]	_	_
17-4	1878-1879	,	_	_	_	_
17-5	1880-1892	Mtb-mediated	abstract[115]	giv[115]	coref	17-9[117_115]
17-6	1893-1899	Parkin	person|abstract[115]	giv|giv[115]	coref	18-4
17-7	1900-1910	production	abstract[115]	giv[115]	_	_
17-8	1911-1920	decreased	_	_	_	_
17-9	1921-1925	MFN2	object|abstract[117]	giv|giv[117]	coref	26-3
17-10	1926-1936	production	abstract[117]	giv[117]	_	_
17-11	1937-1940	via	abstract[117]	giv[117]	_	_
17-12	1941-1955	ubiquitination	abstract[117]|substance	giv[117]|giv	_	_
17-13	1956-1957	.	_	_	_	_

#Text=The production of Parkin is induced by ER stress .
18-1	1958-1961	The	abstract[119]	new[119]	coref	20-9[133_119]
18-2	1962-1972	production	abstract[119]	new[119]	_	_
18-3	1973-1975	of	abstract[119]	new[119]	_	_
18-4	1976-1982	Parkin	abstract[119]|person	new[119]|giv	coref	20-9
18-5	1983-1985	is	_	_	_	_
18-6	1986-1993	induced	_	_	_	_
18-7	1994-1996	by	_	_	_	_
18-8	1997-1999	ER	person|abstract[122]	new|new[122]	coref|coref	19-2[123_122]|19-13
18-9	2000-2006	stress	abstract[122]	new[122]	_	_
18-10	2007-2008	.	_	_	_	_

#Text=Although ER stress plays an important role in mycobacterial infection , Ra-mediated ER stress was stronger than that induced by the virulent strain Rv .
19-1	2009-2017	Although	_	_	_	_
19-2	2018-2020	ER	abstract[123]	giv[123]	coref	19-12[127_123]
19-3	2021-2027	stress	abstract[123]	giv[123]	_	_
19-4	2028-2033	plays	_	_	_	_
19-5	2034-2036	an	abstract[124]	new[124]	coref	30-3[197_124]
19-6	2037-2046	important	abstract[124]	new[124]	_	_
19-7	2047-2051	role	abstract[124]	new[124]	_	_
19-8	2052-2054	in	abstract[124]	new[124]	_	_
19-9	2055-2068	mycobacterial	abstract[124]|abstract[125]	new[124]|giv[125]	coref	25-13[167_125]
19-10	2069-2078	infection	abstract[124]|abstract[125]	new[124]|giv[125]	_	_
19-11	2079-2080	,	_	_	_	_
19-12	2081-2092	Ra-mediated	abstract[127]	giv[127]	coref	20-20[137_127]
19-13	2093-2095	ER	person|abstract[127]	giv|giv[127]	coref	20-20
19-14	2096-2102	stress	abstract[127]	giv[127]	_	_
19-15	2103-2106	was	_	_	_	_
19-16	2107-2115	stronger	_	_	_	_
19-17	2116-2120	than	_	_	_	_
19-18	2121-2125	that	_	_	_	_
19-19	2126-2133	induced	_	_	_	_
19-20	2134-2136	by	_	_	_	_
19-21	2137-2140	the	abstract[129]	giv[129]	coref	20-12[0_129]
19-22	2141-2149	virulent	abstract[129]	giv[129]	_	_
19-23	2150-2156	strain	abstract|abstract[129]	new|giv[129]	_	_
19-24	2157-2159	Rv	abstract[129]	giv[129]	_	_
19-25	2160-2161	.	_	_	_	_

#Text=Also , Ra induced a higher level of Parkin production than Rv , possibly due to different intensities of ER stress .
20-1	2162-2166	Also	_	_	_	_
20-2	2167-2168	,	_	_	_	_
20-3	2169-2171	Ra	person	giv	_	_
20-4	2172-2179	induced	_	_	_	_
20-5	2180-2181	a	abstract[131]	new[131]	_	_
20-6	2182-2188	higher	abstract[131]	new[131]	_	_
20-7	2189-2194	level	abstract[131]	new[131]	_	_
20-8	2195-2197	of	abstract[131]	new[131]	_	_
20-9	2198-2204	Parkin	abstract[131]|person|abstract[133]	new[131]|giv|giv[133]	coref|coref	22-4|22-4[145_133]
20-10	2205-2215	production	abstract[131]|abstract[133]	new[131]|giv[133]	_	_
20-11	2216-2220	than	abstract[131]|abstract[133]	new[131]|giv[133]	_	_
20-12	2221-2223	Rv	abstract[131]|abstract[133]|substance	new[131]|giv[133]|giv	coref	21-3
20-13	2224-2225	,	_	_	_	_
20-14	2226-2234	possibly	_	_	_	_
20-15	2235-2238	due	_	_	_	_
20-16	2239-2241	to	_	_	_	_
20-17	2242-2251	different	abstract[135]	new[135]	_	_
20-18	2252-2263	intensities	abstract[135]	new[135]	_	_
20-19	2264-2266	of	abstract[135]	new[135]	_	_
20-20	2267-2269	ER	abstract[135]|person|abstract[137]	new[135]|giv|giv[137]	coref|coref	21-5|21-6[0_137]
20-21	2270-2276	stress	abstract[135]|abstract[137]	new[135]|giv[137]	_	_
20-22	2277-2278	.	_	_	_	_

#Text=Compared to Rv , ER stress response is strong in Ra-infected macrophages .
21-1	2279-2287	Compared	_	_	_	_
21-2	2288-2290	to	_	_	_	_
21-3	2291-2293	Rv	substance	giv	ana	22-1
21-4	2294-2295	,	_	_	_	_
21-5	2296-2298	ER	person|event[141]	giv|new[141]	coref	23-2
21-6	2299-2305	stress	abstract|event[141]	giv|new[141]	coref	23-3
21-7	2306-2314	response	event[141]	new[141]	_	_
21-8	2315-2317	is	_	_	_	_
21-9	2318-2324	strong	_	_	_	_
21-10	2325-2327	in	_	_	_	_
21-11	2328-2339	Ra-infected	animal[142]	giv[142]	coref	25-16[0_142]
21-12	2340-2351	macrophages	animal[142]	giv[142]	_	_
21-13	2352-2353	.	_	_	_	_

#Text=It sequentially induced Parkin production and eventually resulted in strong apoptosis .
22-1	2354-2356	It	substance	giv	_	_
22-2	2357-2369	sequentially	_	_	_	_
22-3	2370-2377	induced	_	_	_	_
22-4	2378-2384	Parkin	person|abstract[145]	giv|giv[145]	coref|coref	23-9|23-9[152_145]
22-5	2385-2395	production	abstract[145]	giv[145]	_	_
22-6	2396-2399	and	_	_	_	_
22-7	2400-2410	eventually	_	_	_	_
22-8	2411-2419	resulted	_	_	_	_
22-9	2420-2422	in	_	_	_	_
22-10	2423-2429	strong	abstract[146]	giv[146]	coref	26-5[0_146]
22-11	2430-2439	apoptosis	abstract[146]	giv[146]	_	_
22-12	2440-2441	.	_	_	_	_

#Text=Three ER stress sensor molecules were involved in Parkin production : PERK , IRE1 , and ATF6 .
23-1	2442-2447	Three	object[150]	new[150]	_	_
23-2	2448-2450	ER	person|object[150]	giv|new[150]	coref	25-5
23-3	2451-2457	stress	abstract|object[150]	giv|new[150]	_	_
23-4	2458-2464	sensor	substance|object[150]	new|new[150]	_	_
23-5	2465-2474	molecules	object[150]	new[150]	_	_
23-6	2475-2479	were	_	_	_	_
23-7	2480-2488	involved	_	_	_	_
23-8	2489-2491	in	_	_	_	_
23-9	2492-2498	Parkin	person|abstract[152]	giv|giv[152]	appos|coref	23-12[154_152]|24-16
23-10	2499-2509	production	abstract[152]	giv[152]	_	_
23-11	2510-2511	:	_	_	_	_
23-12	2512-2516	PERK	object|abstract[154]	new|giv[154]	ana	24-1[0_154]
23-13	2517-2518	,	abstract[154]	giv[154]	_	_
23-14	2519-2523	IRE1	abstract[154]|object	giv[154]|new	_	_
23-15	2524-2525	,	abstract[154]	giv[154]	_	_
23-16	2526-2529	and	abstract[154]	giv[154]	_	_
23-17	2530-2534	ATF6	abstract[154]	giv[154]	_	_
23-18	2535-2536	.	_	_	_	_

#Text=These contribute to the generation of reactive oxygen species , which triggers mitochondrial recruitment of Parkin .
24-1	2537-2542	These	abstract	giv	_	_
24-2	2543-2553	contribute	_	_	_	_
24-3	2554-2556	to	_	_	_	_
24-4	2557-2560	the	event[157]	new[157]	_	_
24-5	2561-2571	generation	event[157]	new[157]	_	_
24-6	2572-2574	of	event[157]	new[157]	_	_
24-7	2575-2583	reactive	event[157]|person[159]	new[157]|new[159]	_	_
24-8	2584-2590	oxygen	event[157]|substance|person[159]	new[157]|new|new[159]	_	_
24-9	2591-2598	species	event[157]|person[159]	new[157]|new[159]	_	_
24-10	2599-2600	,	_	_	_	_
24-11	2601-2606	which	_	_	_	_
24-12	2607-2615	triggers	_	_	_	_
24-13	2616-2629	mitochondrial	abstract[160]	new[160]	_	_
24-14	2630-2641	recruitment	abstract[160]	new[160]	_	_
24-15	2642-2644	of	abstract[160]	new[160]	_	_
24-16	2645-2651	Parkin	abstract[160]|person	new[160]|giv	coref	25-7
24-17	2652-2653	.	_	_	_	_

#Text=Our data suggest that ER stress-mediated Parkin is a MFN2 regulator during mycobacterial infection in macrophages .
25-1	2654-2657	Our	person|abstract[163]	giv|giv[163]	ana|coref	28-3|28-3[183_163]
25-2	2658-2662	data	abstract[163]	giv[163]	_	_
25-3	2663-2670	suggest	_	_	_	_
25-4	2671-2675	that	_	_	_	_
25-5	2676-2678	ER	person	giv	_	_
25-6	2679-2694	stress-mediated	_	_	_	_
25-7	2695-2701	Parkin	person	giv	_	_
25-8	2702-2704	is	_	_	_	_
25-9	2705-2706	a	substance[166]	new[166]	_	_
25-10	2707-2711	MFN2	substance[166]	new[166]	_	_
25-11	2712-2721	regulator	substance[166]	new[166]	_	_
25-12	2722-2728	during	substance[166]	new[166]	_	_
25-13	2729-2742	mycobacterial	substance[166]|abstract[167]	new[166]|giv[167]	coref	31-12[205_167]
25-14	2743-2752	infection	substance[166]|abstract[167]	new[166]|giv[167]	_	_
25-15	2753-2755	in	substance[166]|abstract[167]	new[166]|giv[167]	_	_
25-16	2756-2767	macrophages	substance[166]|abstract[167]|animal	new[166]|giv[167]|giv	coref	28-20
25-17	2768-2769	.	_	_	_	_

#Text=Knockdown of MFN2 induces apoptosis by disrupting the mitochondrial network , suppressing the growth of Mtb .
26-1	2770-2779	Knockdown	event[169]	new[169]	_	_
26-2	2780-2782	of	event[169]	new[169]	_	_
26-3	2783-2787	MFN2	event[169]|object	new[169]|giv	coref	27-5
26-4	2788-2795	induces	_	_	_	_
26-5	2796-2805	apoptosis	abstract	giv	coref	27-15
26-6	2806-2808	by	_	_	_	_
26-7	2809-2819	disrupting	_	_	_	_
26-8	2820-2823	the	abstract[173]	new[173]	_	_
26-9	2824-2837	mitochondrial	place|abstract[173]	giv|new[173]	coref	27-12
26-10	2838-2845	network	abstract[173]	new[173]	_	_
26-11	2846-2847	,	_	_	_	_
26-12	2848-2859	suppressing	_	_	_	_
26-13	2860-2863	the	event[174]	new[174]	_	_
26-14	2864-2870	growth	event[174]	new[174]	_	_
26-15	2871-2873	of	event[174]	new[174]	_	_
26-16	2874-2877	Mtb	event[174]|abstract	new[174]|giv	coref	28-18[188_0]
26-17	2878-2879	.	_	_	_	_

#Text=A low level of MFN2 decreases the MMP , leading to mitochondrial dysfunction and apoptosis .
27-1	2880-2881	A	abstract[176]	new[176]	_	_
27-2	2882-2885	low	abstract[176]	new[176]	_	_
27-3	2886-2891	level	abstract[176]	new[176]	_	_
27-4	2892-2894	of	abstract[176]	new[176]	_	_
27-5	2895-2899	MFN2	abstract[176]|object	new[176]|giv	coref	28-9
27-6	2900-2909	decreases	_	_	_	_
27-7	2910-2913	the	object[178]	giv[178]	_	_
27-8	2914-2917	MMP	object[178]	giv[178]	_	_
27-9	2918-2919	,	_	_	_	_
27-10	2920-2927	leading	_	_	_	_
27-11	2928-2930	to	_	_	_	_
27-12	2931-2944	mitochondrial	abstract|abstract[180]	giv|new[180]	coref	29-11
27-13	2945-2956	dysfunction	abstract[180]	new[180]	_	_
27-14	2957-2960	and	_	_	_	_
27-15	2961-2970	apoptosis	abstract	giv	coref	29-14
27-16	2971-2972	.	_	_	_	_

#Text=Therefore , our data suggest that regulation of MFN2 levels is important for suppressing the survival of Mtb in macrophages .
28-1	2973-2982	Therefore	_	_	_	_
28-2	2983-2984	,	_	_	_	_
28-3	2985-2988	our	person|abstract[183]	giv|giv[183]	ana	29-4
28-4	2989-2993	data	abstract[183]	giv[183]	_	_
28-5	2994-3001	suggest	_	_	_	_
28-6	3002-3006	that	_	_	_	_
28-7	3007-3017	regulation	abstract[184]	new[184]	_	_
28-8	3018-3020	of	abstract[184]	new[184]	_	_
28-9	3021-3025	MFN2	abstract[184]|abstract|abstract[186]	new[184]|giv|giv[186]	coref	30-1
28-10	3026-3032	levels	abstract[184]|abstract[186]	new[184]|giv[186]	_	_
28-11	3033-3035	is	_	_	_	_
28-12	3036-3045	important	_	_	_	_
28-13	3046-3049	for	_	_	_	_
28-14	3050-3061	suppressing	_	_	_	_
28-15	3062-3065	the	event[187]	giv[187]	_	_
28-16	3066-3074	survival	event[187]	giv[187]	_	_
28-17	3075-3077	of	event[187]	giv[187]	_	_
28-18	3078-3081	Mtb	event[187]|abstract[188]	giv[187]|giv[188]	coref	30-15[200_188]
28-19	3082-3084	in	event[187]|abstract[188]	giv[187]|giv[188]	_	_
28-20	3085-3096	macrophages	event[187]|abstract[188]|animal	giv[187]|giv[188]|giv	coref	30-17
28-21	3097-3098	.	_	_	_	_

#Text=In summary , we found that Mtb-induced ER stress increases mitochondrial fragmentation and apoptosis .
29-1	3099-3101	In	_	_	_	_
29-2	3102-3109	summary	abstract	new	_	_
29-3	3110-3111	,	_	_	_	_
29-4	3112-3114	we	person	giv	_	_
29-5	3115-3120	found	_	_	_	_
29-6	3121-3125	that	_	_	_	_
29-7	3126-3137	Mtb-induced	abstract[192]	new[192]	_	_
29-8	3138-3140	ER	abstract[192]	new[192]	_	_
29-9	3141-3147	stress	abstract[192]	new[192]	_	_
29-10	3148-3157	increases	_	_	_	_
29-11	3158-3171	mitochondrial	abstract|abstract[194]	giv|giv[194]	_	_
29-12	3172-3185	fragmentation	abstract[194]	giv[194]	_	_
29-13	3186-3189	and	_	_	_	_
29-14	3190-3199	apoptosis	abstract	giv	_	_
29-15	3200-3201	.	_	_	_	_

#Text=MFN2 plays a key role in disrupting mitochondria , which suppresses the growth of Mtb in macrophages .
30-1	3202-3206	MFN2	object	giv	coref	31-3
30-2	3207-3212	plays	_	_	_	_
30-3	3213-3214	a	abstract[197]	giv[197]	_	_
30-4	3215-3218	key	abstract[197]	giv[197]	_	_
30-5	3219-3223	role	abstract[197]	giv[197]	_	_
30-6	3224-3226	in	_	_	_	_
30-7	3227-3237	disrupting	_	_	_	_
30-8	3238-3250	mitochondria	place	giv	_	_
30-9	3251-3252	,	_	_	_	_
30-10	3253-3258	which	_	_	_	_
30-11	3259-3269	suppresses	_	_	_	_
30-12	3270-3273	the	event[199]	new[199]	_	_
30-13	3274-3280	growth	event[199]	new[199]	_	_
30-14	3281-3283	of	event[199]	new[199]	_	_
30-15	3284-3287	Mtb	event[199]|object[200]	new[199]|giv[200]	_	_
30-16	3288-3290	in	event[199]|object[200]	new[199]|giv[200]	_	_
30-17	3291-3302	macrophages	event[199]|object[200]|animal	new[199]|giv[200]|giv	_	_
30-18	3303-3304	.	_	_	_	_

#Text=Therefore , MFN2 may be a target for host-derived therapeutics against mycobacterial infection .
31-1	3305-3314	Therefore	_	_	_	_
31-2	3315-3316	,	_	_	_	_
31-3	3317-3321	MFN2	abstract	giv	coref	31-6[203_0]
31-4	3322-3325	may	_	_	_	_
31-5	3326-3328	be	_	_	_	_
31-6	3329-3330	a	abstract[203]	giv[203]	_	_
31-7	3331-3337	target	abstract[203]	giv[203]	_	_
31-8	3338-3341	for	abstract[203]	giv[203]	_	_
31-9	3342-3354	host-derived	abstract[203]|abstract[204]	giv[203]|new[204]	_	_
31-10	3355-3367	therapeutics	abstract[203]|abstract[204]	giv[203]|new[204]	_	_
31-11	3368-3375	against	abstract[203]|abstract[204]	giv[203]|new[204]	_	_
31-12	3376-3389	mycobacterial	abstract[203]|abstract[204]|abstract[205]	giv[203]|new[204]|giv[205]	_	_
31-13	3390-3399	infection	abstract[203]|abstract[204]|abstract[205]	giv[203]|new[204]|giv[205]	_	_
31-14	3400-3401	.	_	_	_	_
